| Laura Newman: Medical Writer & Editor | _____Email______ newman@nasw.org |
| Home | Resumé | Clients | Credits | Contact |
Selected Writing SamplesDownload an MS-Word copy of this page.OncologyEnsuring patient safety, credibility in clinical trials. Journal of Oncology Practice. 2007.Preparing for Community Clinical Oncology Program budget cuts. Journal of Oncology Practice. June 2007:219-220. Clinical cancer advances 2006:major research advances in cancer treatment, prevention, and screening. Journal of Oncology Practice. May 2007. Despite efficacy of prophylactic mastectomy, procedure lacks few enthusiasts. J Natl Cancer Inst. 2001;93(5):338-9. Triple therapy offers local control of high-risk PCA. Urology Times. Sept. 2003. Prophylactic oophorectomy in the genome age: balancing new data against uncertainties. J Natl. Cancer Inst. 2001;93(3):173-5. Developing technologies for the early detection of breast cancer. Institute of Medicine. National Academies Press, 2001. Studies raise questions about link between HPC2 Gene and PCA. Urology Times, July 1, 2001. Intravescical gemcitabine shows promise for TCC. Urology Times. May 1, 2002. Larger debate underlies spiral CT screening for lung cancer. Journal National Cancer Inst.. 2000 April 19; 92(8): 592-4. Sentinel lymph node biopsy: is omitting regional lymph node biopsy justifiable? Dermatology Times. Sept. 1, 2004. New tumor markers and melanoma: study shows potential clinical urility. Dermatology Times. May 1, 2004. Triple therapy offers local control for high-risk prostate cancers. Urology Times. Sept. 1, 2003, Novel proteomics test detects 95% of prostate cancers. Urology Times. Dec. 2002. Nomogram for predicting PCa recurrence is validated. Urology Times. Dec. 2002. Second cancer network [National Comprehensive Cancer Network] meeting tackles wooing managed care. Report from the field. Medical Outcomes & Guidelines Alert. March 14, 1997. New HRT outcomes studies offer guidance on screening for endometrial cancer. Rx outcomes report. Medical Outcomes & Guidelines Alert. January 22, 1998. Neurology
FDA advisory panel recommends approval of Tysabri, Appl
Neurol. April 2006.
Oxford study finds strokes more frequent than heart attacks. Emerg Med News. April 2006. Neutralizing antibodies to Interferon: clinically relevant to MS treatment. Applied Neurol. Oct. 2005. Postoperative chemotherapy bolsters five-year outcomes in early childhood medulloblastomas. Neurology Today. 2005. 5; (7):67. First workshop on MS research sets research priorities. Neurology Today. 2005; 5(7): 57. Career opportunities expand in cancer pain and palliative care. Appl Neurol. June 2005 Chronic IllnessesUS Institute of Medicine urges more HIV-Prevention efforts. Lancet. 2000; 356:1252.New Dartmouth Atlas: improving US cardiac care? Lancet. 2000. 356: 660. Should diabetics with chest pain be triaged differently? Researchers find no difference in post-admission complication rates. WebMD Medical News. March 24, 2000. Cardiac troponin levels and heart failure: is the data in? WebMD Medical News. Oct. 7, 1999. Etanercept for juvenile rheumatoid arthritis demonstrates effectiveness in battling treatment refractory disease. March 15, 2000. ACC, AHA, ACP-ASIM join forces on chronic stable angina guidelines. Medical Outcomes & Guidelines Alert. July 1, 1999. Prescribing errors escalate with complex HIV regimens. Medical Outcomes & Guidelines Alert. October 8, 1998. ImagingThe next wave in breast cancer management. Medical Solutions. Dec. 2007.The next frontier: an integrated medical information technology platform. Medical Solutions. Larger debate underlies spiral CT screening for lung cancer. J Natl Cancer Inst. 2000; 92(8):592-4. Seed targeting improved with hybrid imaging techniques.Urology Times. Sept. 2003. CT vs. CT-MR: Which method is better post-implant? Uoology Times. Set. 2003. Brain spectroscopy shows metabolic changes in patients with major depression. WebMD Medical News. November 15, 2000. Health
Policy and Clinical Practice
|